Jun 14, 2002

Efficacy of intravenous immunoglobulin in the prevention of pneumonia in patients with common variable immunodeficiency

The Journal of Allergy and Clinical Immunology
Paula Jane BusseCharlotte Cunningham-Rundles

Abstract

Common variable immunodeficiency (CVID) is a primary immune disorder characterized by antibody deficiency and a decrease in serum IgG and IgA, IgM, or both levels at least 2 SDs below the mean for age and not attributed to other known immunologic disorders. These patients often present with frequent and severe episodes of pneumonia before diagnosis. The standard treatment, intravenous immunoglobulin (IVIG), has been available for the past 20 years. No large-scale study has compared the incidence of pneumonia in these patients before and after IVIG treatment. The aim of this study was to document the effectiveness of intravenous immunoglobulin treatment on the incidence of pneumonia in patients with CVID. We performed chart reviews and interviews of patients with laboratory-confirmed CVID seen at our clinical center. The number of episodes of pneumonia was documented before and after treatment with immunoglobulin replacement therapy. The histories of 50 patients were reviewed (mean current age, 42 +/- 16.3 years; age range, 10-78 years; 20 male and 30 female patients). Forty-two (84%) of the 50 patients with CVID had pneumonia at least once before receiving immunoglobulin treatment, and 11 of 42 of these patients had multiple ep...Continue Reading

  • References
  • Citations

References

  • We're still populating references for this paper, please check back later.
  • References
  • Citations

Citations

  • This paper may not have been cited yet.

Mentioned in this Paper

Immunologic Deficiency Syndromes
Immune System Diseases
Immunoglobulin Activity
Immunoglobulins
Common Variable Immunodeficiency
Malnutrition
Gamma globulin
Normal Serum Globulin Therapy
Pneumonia, Bacterial
Wiskott-Aldrich Syndrome

About this Paper

Related Feeds

Bacterial Pneumonia (ASM)

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Bacterial Pneumonia

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Related Papers

Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi
Zahra PourpakMostafa Moin
The Journal of Allergy and Clinical Immunology
Joris van der HeijdenTaco W Kuijpers
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology
Waleed Al-Herz, Stephen J McGeady
Journal of Clinical Immunology
Jana NechvatalovaJiri Litzman
© 2020 Meta ULC. All rights reserved